Bioreactors Sartorius Opens New Bioreactor Production in Guxhagen, Germany
Laboratory and pharmaceutical supplier Sartorius has opened a new bioreactor manufacturing plant in Cuxhagen, Germany. The new 10,000 square feet building complex provides space for a high-tech manufacturing hall and offices for around 240 employees, replacing Sartorius former facility in Melsungen, Germany, that had reached maximum capacity limits.
Goettingen/Germany – Approximately 18 million euros were invested in the plant at which Sartorius now manufactures bioreactors and further production equipment for customers in the biopharmaceutical industry, Sartorius speakers said.
"The new plant enables us to substantially enhance our manufacturing processes and creates additional capacity for us in view of the rising demand for biopharmaceutical production equipment. As a result, we are optimally prepared for further expansion, especially for single-use bioreactors," added Joachim Kreuzburg, the CEO and Executive Board Chairman of Sartorius.
Do you want to know more? In our interview with Maik W. Jornitz, Sartorius' Sr. Vice President, Product Management, Bioprocess Solutions, talks about the potentials of single–use within changing scenario in the bioprocess industry.